Aktieanalys

BioInvent: New BI-1910 and BI-1206 data - Redeye

{newsItem.title}

Redeye Publicerad: 08 Jan 12:35

Redeye comments on the new data from the triple combination study of BI-1206 and the phase I monotherapy data for BI-1910.

Länk till analysen i sin helhet: https://www.redeye.se/research/1066888/bioinvent-new-bi-1910-and-bi-1206-data?utm_source=finwire&utm_medium=RSS

Nyheter om Bioinvent

Läses av andra just nu

Om aktien Bioinvent

Senaste nytt